• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia.

作者信息

Smilde T J, van den Berkmortel F W, Wollersheim H, van Langen H, Kastelein J J, Stalenhoef A F

机构信息

University Hospital Nijmegen, Nijmegen, The Netherlands.

出版信息

Eur J Clin Invest. 2000 Jun;30(6):473-80. doi: 10.1046/j.1365-2362.2000.00654.x.

DOI:10.1046/j.1365-2362.2000.00654.x
PMID:10849014
Abstract

BACKGROUND

Early in the process of atherosclerosis, changes in vessel wall stiffness and thickness may occur. The present study evaluates the effect of cholesterol reduction on artery wall stiffness and intima media thickness in patients with familial hypercholesterolaemia (FH).

MATERIALS AND METHODS

Forty-five patients with familial hypercholesterolaemia (mean age 46+/-10 years) with untreated LDL cholesterol concentration > 9 mmol L(-1), were studied before and after one year of cholesterol lowering therapy with statins (simvastatin, atorvastatin 40-80 mg day(-1). The distensibility (DC in 10-3 kPa(-1) and compliance (CC in mm2. kPa(-1) of the common carotid artery (CCA) (right and left side) and common femoral artery (CFA) (right side) were determined by a wall track system (Pie Medical). The intima media thickness (IMT) (both right and left) of the CCA, bulb (BUL), internal carotid artery (ICA) and CFA were measured in mm by high-resolution ultrasound (Biosound).

RESULTS

The mean concentration of total cholesterol (TC), LDL-cholesterol (LDL-C) and triglycerides (TG) were reduced significantly by 43%, 51% and 25%, respectively, whereas HDL-cholesterol (HDL-C) increased by 13% (P<0.001). In the CFA, the DC and CC increased significantly (DC from 7.9+/-3.0 to 9.1+/-3.7 in 10(-3) kPa(-1); CC 0.5+/-0.2-0.6+/-0.3 in mm2. kPa(-1), whereas the DC and CC did not change in the CCA. In contrast, the IMT of the CCA decreased significantly in both men and women whereas an IMT decrease was also seen in the BUL and ICA in premenopausal women. A LDL-cholesterol reduction of 44.8% and 45.4% was necessary to induce significant decreases in IMT and increases in DC and CC.

CONCLUSIONS

One year of cholesterol lowering therapy in FH decreases the wall stiffness in the CFA and the arterial wall thickness in the CCA.

摘要

相似文献

1
The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia.
Eur J Clin Invest. 2000 Jun;30(6):473-80. doi: 10.1046/j.1365-2362.2000.00654.x.
2
Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia.心血管疾病高危患者的颈动脉和股动脉壁厚度及僵硬度,特别关注高同型半胱氨酸血症。
Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1958-63. doi: 10.1161/01.atv.18.12.1958.
3
Effects of low and high doses of atorvastatin on arterial compliance.低剂量和高剂量阿托伐他汀对动脉顺应性的影响。
Jpn Heart J. 2003 Nov;44(6):953-61. doi: 10.1536/jhj.44.953.
4
Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.比较家族性高胆固醇血症患者强化降脂与常规降脂对动脉粥样硬化进展及内中膜厚度影响的临床试验的原理、设计和基线特征:阿托伐他汀与辛伐他汀对动脉粥样硬化进展(ASAP)的研究。
Clin Drug Investig. 2000;20(2):67-79. doi: 10.2165/00044011-200020020-00001.
5
The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study.阿托伐他汀与辛伐他汀对动脉粥样硬化进展影响(ASAP)研究中股动脉内膜中层厚度及斑块评分的意义
Eur J Cardiovasc Prev Rehabil. 2003 Dec;10(6):451-5. doi: 10.1097/01.hjr.0000103277.02552.1e.
6
Simvastatin with or without ezetimibe in familial hypercholesterolemia.辛伐他汀联合或不联合依折麦布治疗家族性高胆固醇血症
N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30.
7
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.积极降脂与常规降脂对家族性高胆固醇血症患者动脉粥样硬化进展的影响(ASAP):一项前瞻性、随机、双盲试验
Lancet. 2001 Feb 24;357(9256):577-81. doi: 10.1016/s0140-6736(00)04053-8.
8
The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT).
Eur J Vasc Endovasc Surg. 2002 Apr;23(4):358-64. doi: 10.1053/ejvs.2002.1611.
9
LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia.高胆固醇血症患者中,低密度脂蛋白颗粒大小与颈动脉和股动脉内膜中层厚度及斑块发生情况的关系。
J Intern Med. 2000 Jul;248(1):42-52. doi: 10.1046/j.1365-2796.2000.00698.x.
10
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.托彻普对家族性高胆固醇血症患者颈动脉粥样硬化的影响。
N Engl J Med. 2007 Apr 19;356(16):1620-30. doi: 10.1056/NEJMoa071359. Epub 2007 Mar 26.

引用本文的文献

1
Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia.冠状动脉钙化与家族性高胆固醇血症患者的动脉僵硬度和低密度脂蛋白胆固醇负荷独立相关。
J Clin Med. 2025 Feb 13;14(4):1245. doi: 10.3390/jcm14041245.
2
Vascular Aging: Assessment and Intervention.血管衰老:评估与干预。
Clin Interv Aging. 2023 Aug 17;18:1373-1395. doi: 10.2147/CIA.S423373. eCollection 2023.
3
Association between Low-Density Lipoprotein Cholesterol and Vascular Biomarkers in Primary Prevention.
一级预防中低密度脂蛋白胆固醇与血管生物标志物之间的关联
Biomedicines. 2023 Jun 18;11(6):1753. doi: 10.3390/biomedicines11061753.
4
Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis.脉搏波速度作为家族性高胆固醇血症患者动脉僵硬度的一项指标:系统评价与荟萃分析
Arch Med Sci. 2019 Oct;15(6):1365-1374. doi: 10.5114/aoms.2019.89450. Epub 2019 Nov 3.
5
Arterial Stiffness and Hypertension - Which Comes First?动脉僵硬度与高血压——何者为先?
Maedica (Bucur). 2017 Sep;12(3):184-190.
6
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.在糖尿病前期个体中,ADMA、内皮祖细胞和传统心血管危险因素对脉搏波速度的影响。
Cardiovasc Diabetol. 2012 Nov 15;11:141. doi: 10.1186/1475-2840-11-141.
7
Vascular stiffness and increased pulse pressure in the aging cardiovascular system.衰老的心血管系统中的血管僵硬和脉搏压升高。
Cardiol Res Pract. 2011;2011:263585. doi: 10.4061/2011/263585. Epub 2011 Aug 2.
8
Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.慢性抗胆固醇治疗对代谢综合征中微血管稀疏发展的影响。
Microcirculation. 2009 Nov;16(8):667-84. doi: 10.3109/10739680903133722.
9
In vivo comparison of atherosclerotic plaque progression with vessel wall strain and blood flow velocity in apoE(-/-) mice with MR microscopy at 17.6 T.在17.6T条件下,利用磁共振显微镜对载脂蛋白E基因敲除(apoE(-/-))小鼠的动脉粥样硬化斑块进展与血管壁应变及血流速度进行体内比较。
MAGMA. 2009 Jun;22(3):159-66. doi: 10.1007/s10334-008-0160-0. Epub 2009 Jan 20.
10
Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging.他汀类药物起始治疗后动脉结构和功能的早期变化:通过磁共振成像进行量化
Atherosclerosis. 2008 Apr;197(2):951-8. doi: 10.1016/j.atherosclerosis.2007.09.001. Epub 2007 Oct 30.